GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abaxis Inc (NAS:ABAX) » Definitions » Gross-Profit-to-Asset %

Abaxis (Abaxis) Gross-Profit-to-Asset % : 43.92% (As of Mar. 2018)


View and export this data going back to 1992. Start your Free Trial

What is Abaxis Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Abaxis's annualized Gross Profit for the quarter that ended in Mar. 2018 was $149.3 Mil. Abaxis's average Total Assets over the quarter that ended in Mar. 2018 was $339.9 Mil. Therefore, Abaxis's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2018 was 43.92%.


Abaxis Gross-Profit-to-Asset % Historical Data

The historical data trend for Abaxis's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abaxis Gross-Profit-to-Asset % Chart

Abaxis Annual Data
Trend Mar09 Mar10 Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 40.06 44.80 45.61 43.62 41.32

Abaxis Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.94 41.03 40.38 39.08 43.92

Competitive Comparison of Abaxis's Gross-Profit-to-Asset %

For the Diagnostics & Research subindustry, Abaxis's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abaxis's Gross-Profit-to-Asset % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Abaxis's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Abaxis's Gross-Profit-to-Asset % falls into.



Abaxis Gross-Profit-to-Asset % Calculation

Abaxis's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2018 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Mar. 2018 )/( (Total Assets (A: Mar. 2017 )+Total Assets (A: Mar. 2018 ))/ count )
=133.609/( (305.646+341.103)/ 2 )
=133.609/323.3745
=41.32 %

Abaxis's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2018 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2018 )/( (Total Assets (Q: Dec. 2017 )+Total Assets (Q: Mar. 2018 ))/ count )
=149.312/( (338.763+341.103)/ 2 )
=149.312/339.933
=43.92 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2018) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Abaxis Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Abaxis's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Abaxis (Abaxis) Business Description

Traded in Other Exchanges
N/A
Address
Abaxis Inc manufactures point-of-care blood analysis instruments and consumables for medical and veterinary care providers. The medical segment sells Piccolo Chemistry Analyzers, which can provide results about a blood sample in 12 minutes, and related reagents to physicians, hospitals, pharmacies, and other healthcare providers. The veterinary segment generates the majority of the firm's total revenue and sells products to animal hospitals, veterinary clinics, and private research laboratories. Products in this segment include the VetScan VS2 chemistry analyzer, animal-specific reagents, and rapid tests for canine and feline diseases. The vast majority of the firm's revenue comes from North America and Europe.
Executives
Richard Bastiani director C/O ABAXIS INC, 3240 WHIPPLE RD, UNION CITY CA 94587
Taylor Dean Ross Jr officer: CFO and VP of Finance C/O ABAXIS INC, 3240 WHIPPLE ROAD, UNION CITY CA 94587
Clinton Severson director, officer: CEO & Board Chairman C/O ABAXIS INC, 3240 WHIPPLE ROAD, UNION CITY CA 94587
Michael D Casey director ALLOS THERAPEUTICS, INC., 11080 CIRCLEPOINT ROAD, SUITE 200, WESTMINSTER CO 80020